€53.70
0.09% yesterday
Madrid, Aug 11, 05:35 pm CET
ISIN
ES0157261019
Symbol
ROVI
Index

Laboratorios Farmaceuticos Stock price

€53.70
-2.00 3.59% 1M
-1.80 3.24% 6M
-9.25 14.69% YTD
-22.50 29.53% 1Y
+2.45 4.78% 3Y
+26.20 95.27% 5Y
+40.14 296.02% 10Y
+44.25 468.25% 20Y
Madrid, Closing price Mon, Aug 11 2025
-0.05 0.09%
ISIN
ES0157261019
Symbol
ROVI
Index
Industry

Key metrics

Basic
Market capitalization
€2.7b
Enterprise Value
€2.8b
Net debt
€81.7m
Cash
€47.6m
Shares outstanding
51.2m
Valuation (TTM | estimate)
P/E
20.5 | 21.1
P/S
3.6 | 3.6
EV/Sales
3.7 | 3.7
EV/FCF
37.3
P/B
4.8
Dividends
DPS
€0.94
Yield 1Y | 5Y
1.7% | 1.6%
Growth 1Y | 5Y
-15.3% | 39.8%
Payout 1Y | 3Y
41.3% | 34.9%
Increased
0 Years
Financials (TTM | estimate)
Revenue
€749.0m | €739.9m
EBITDA
€203.3m | €198.6m
EBIT
€174.0m | €168.1m
Net Income
€132.3m | €130.1m
Free Cash Flow
€74.2m
Growth (TTM | estimate)
Revenue
-24.5% | -3.1%
EBITDA
-30.3% | -4.3%
EBIT
-33.0% | -6.4%
Net Income
-33.9% | -5.0%
Free Cash Flow
113.5%
Margin (TTM | estimate)
Gross
63.8%
EBITDA
27.2% | 26.8%
EBIT
23.2%
Net
17.7% | 17.6%
Free Cash Flow
9.9%
Financial Health
Equity Ratio
68.8%
Return on Equity
23.9%
ROCE
25.5%
ROIC
20.0%
Debt/Equity
0.2
More
EPS
€2.6
FCF per Share
€1.5
Short interest
-
Employees
2k
Rev per Employee
€350.0k
Show more

Is Laboratorios Farmaceuticos a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.

Laboratorios Farmaceuticos Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a Laboratorios Farmaceuticos forecast:

11x Buy
73%
4x Hold
27%

Analyst Opinions

15 Analysts have issued a Laboratorios Farmaceuticos forecast:

Buy
73%
Hold
27%

Financial data from Laboratorios Farmaceuticos

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
749 749
24% 24%
100%
- Direct Costs 271 271
30% 30%
36%
478 478
21% 21%
64%
- Selling and Administrative Expenses 141 141
9% 9%
19%
- Research and Development Expense - -
-
-
203 203
30% 30%
27%
- Depreciation and Amortization 29 29
8% 8%
4%
EBIT (Operating Income) EBIT 174 174
33% 33%
23%
Net Profit 132 132
34% 34%
18%

In millions EUR.

Don't miss a Thing! We will send you all news about Laboratorios Farmaceuticos directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Laboratorios Farmaceúticos Rovi SA engages in the research, development, manufacture, and marketing of small molecule and specialty biologic drugs. It operates through the following business segments: Manufacturing, Marketing, and Other. The Manufacturing segment obtains its income from service contracts that relate to the finalization of the pharmaceutical product production process for external entities and the manufacture of products to be subsequently marketed by other group companies. The Marketing segment purchases and sells pharmaceutical products. The Other segment includes other services, research, and development activities that are not significant for the group. The company was founded on December 21, 1946 and is headquartered in Madrid, Spain.

Head office Spain
CEO Juan Encina
Employees 2,197
Founded 1946
Website www.rovi.es

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today